CRISPR Therapeutics AG Business Operations Contracts & Agreements

11 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 1 to the Amended and Restated Joint Development and Commercialization Agreement, dated December 12, 2023, by and between, on the one hand, Vertex Pharmaceuticals...
Development Agreements
CRISPR Therapeutics AG
Biotechnology
2023
First Amendment to the Strategic Collaboration and License Agreement dated March 17, 2021, between CRISPR Therapeutics AG and Vertex Pharmaceuticals Incorporated
Collaboration Agreements
CRISPR Therapeutics AG
Biotechnology
2021
Amendment No. 2 to Research Collaboration Agreement by and between CRISPR Therapeutics AG and ViaCyte, Inc., dated as of October 21, 2019
Collaboration Agreements
CRISPR Therapeutics AG
Biotechnology
2020
Amendment No. 1 to Research Collaboration Agreement by and between CRISPR Therapeutics AG and ViaCyte, Inc., dated as of April 30, 2019
Collaboration Agreements
CRISPR Therapeutics AG
Biotechnology
2020
Termination Agreement, dated December 27, 2019, by and between CRISPR Therapeutics AG and Rodger Novak
Termination Agreements
CRISPR Therapeutics AG
Biotechnology
2019
Strategic Collaboration and License Agreement dated June 6, 2019, between CRISPR Therapeutics AG and Vertex Pharmaceuticals Incorporated
Collaboration Agreements
CRISPR Therapeutics AG
Biotechnology
MA
2019
Amendment No. 2 to the Strategic Collaboration, Option and License Agreement by and between, on the one hand, Vertex Pharmaceuticals Incorporated and Vertex Pharmaceuticals...
Collaboration Agreements
CRISPR Therapeutics AG
Biotechnology
2019
Advisory Agreement by and between CRISPR Therapeutics AG and Dr. Anthony Coles, dated as of December 20, 2017
Advisory Agreements
CRISPR Therapeutics AG
Biotechnology
MA
2017
Amendment No. 1 to the Strategic Collaboration, Option and License Agreement by and between, on the one hand, Vertex Pharmaceuticals Incorporated and Vertex Pharmaceuticals...
Collaboration Agreements
CRISPR Therapeutics AG
Biotechnology
MA
2017
Joint Development and Commercialization Agreement by and between, on the one hand, Vertex Pharmaceuticals Incorporated and Vertex Pharmaceuticals (Europe) Limited, and on the...
Development Agreements
CRISPR Therapeutics AG
Biotechnology
DE
2017
[***] INDICATES MATERIAL THAT HAS BEEN OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED. ALL SUCH OMITTED MATERIAL HAS BEENFILED WITH THE SECURITIES AND EXCHANGE...
Services Agreements
CRISPR Therapeutics AG
Biotechnology
CA
2016